Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Obstetrics and Gynecology|February 27, 2025
Fragmented Care and Guideline-Concordant Treatment in Locally Advanced Cervical CancerAudrey Mvemba, Jessica Liang, Megan Swanson, et al.Journal of Geriatric Oncology|December 21, 2024
The pervasive impact of frailty on ovarian cancer care and the role of prehabilitation: Qualitative perspectives of key stakeholdersStephanie Cham, Rachel A Pozzar, Neil Horowitz, et al.Gynecologic Oncology Reports|July 30, 2025
Complete response of somatic POLE-ultramutated recurrent undifferentiated uterine sarcoma to pembrolizumab and concurrent radiotherapyNatasha E Charewycz, I-Chow Joe Hsu, Kevin Lu, et al.American Journal of Perinatology|May 3, 2021
Hospital Admissions from the Emergency Department and Subsequent Critical Care Interventions for Influenza during PregnancyNicole Krenitsky, Timothy Wen, Stephanie Cham, et al.American Journal of Obstetrics and Gynecology|February 22, 2025
Delay to timely treatment in locally advanced cervical cancer: insurance inequities in access to gynecologic oncologyJessica Liang, Audrey Mvemba, Megan Swanson, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
Frailty and Days at Home After Ovarian Cancer Surgery- A Patient-Centered Outcome for Older AdultsStephanie Cham, Siqi Gan, W John Boscardin, et al.Gynecologic Oncology|December 4, 2020
Advanced ovarian cancer and cytoreductive surgery: Independent validation of a risk-calculator for perioperative adverse eventsAlli M Straubhar, Jennifer L Wolf, Ms Qin C Zhou, et al.Gynecologic Oncology|March 28, 2017
Utility of radiation therapy for early-stage uterine papillary serous carcinomaStephanie Cham, Yongmei Huang, Ana I Tergas, et al.Gynecologic Oncology Reports|July 18, 2025
Phase 2 study of Wee1 inhibitor adavosertib in recurrent uterine carcinosarcomaStephanie Cham, Niya Xiong, Nabihah Tayob, et al.American Journal of Obstetrics and Gynecology|February 17, 2019
Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancerStephanie Cham, Ling Chen, Caryn M St Clair, et al.Pageof 3